Estrogen replacement therapy and cardiovascular events: the cardiovascular health study
نویسندگان
چکیده
منابع مشابه
Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
Walsh • Focus on cardiovascular health C disease is the leading cause of death in the United States today. Fully 52% of women will die of cardiovascular disease, far exceeding the percentage who will die of all cancers combined, and far in excess of the 4% who will die of breast cancer.1 It has been known since the initial findings of the Framingham Study, however, that women have a 20-year adv...
متن کاملSelective estrogen receptor modulators and cardiovascular events.
ost of the previous observational studies suggest that estrogen replacement therapy reduces cardiovascular risks,1 but meta-analysis of randomized clinical trials showed increased risk of hormone replacement therapy for cardiovascular events.2 Both hypercoagulability and upregulation of inflammation-sensitive proteins could underline the increased risk of estrogen treatment in coronary artery d...
متن کاملEvaluation of the Relationship between Hematological Indices and Cardiovascular Events in Isfahan Cohort Study
Background and Objective: Cardiovascular Disease (CVD) is the leading cause of death in developing countries. Inflammation significantly contributes to the process of atherosclerosis. Therefore, evaluating White Blood Cells (WBC) and platelet counts as markers of inflammatory as well as hematocrit as a marker of blood viscosity may predict coronary events. The present study aimed to evaluate th...
متن کاملThe interaction of vascular stiffness and cardiovascular events in women: insights from The Heart and Estrogen/Progestin Replacement Study.
Hormone Replacement Therapy and Cardiovascular Events T he matter regarding hormone replacement therapy and cardiovascular events has been the subject of multiple publications. While observational studies depicted a protection from coronary events in patients receiving hormone replacement therapy, recent randomized trials have failed to show that promising evidence.1 The Heart and Estrogen/Prog...
متن کاملThe metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.
OBJECTIVE The prevalence of the metabolic syndrome, a potent risk factor for cardiovascular diseases (CVDs), has not been adequately explored in older individuals. Moreover, two sets of criteria have been proposed for the definition of metabolic syndrome, one by the World Health Organization (WHO) and one by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII). We ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2002
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(02)80719-7